Conflicts of interests
AA and MCR report a research grant for preclinical research from Grifols
and from Fisher&Paykel, and payment as Scientific Advisor for Grifols,
outside the submitted work. JL reports receiving an Academic
Collaboration grant funded by Science Foundation Ireland and Aerogen
Inc. for a different study (CHARTER-Ireland). JS is Scientific Advisor
for and has shares in Ockham Biotech Ltd, which holds patents around the
use of inhaled heparin. TW is Chief Investigator of the ACCORD COVID
Research Programme. DS reports personal fees from AstraZeneca, personal
fees from Boehringer Ingelheim, personal fees from Chiesi, personal fees
from Cipla, personal fees from Genentech, personal fees from
GlaxoSmithKline, personal fees from Glenmark, personal fees from
Gossamerbio, personal fees from Menarini, personal fees from
Mundipharma, personal fees from Novartis, personal fees from
Peptinnovate, personal fees from Pfizer, personal fees from Pulmatrix,
personal fees from Theravance, personal fees from Verona, outside the
submitted work. CP reports receiving personal fees from Cipla, Immune
Regulation, EpiEndo and Glycosynnovation, and has equity in Verona
Pharma, outside of the submitted work. All other authors have nothing to
disclose.